Posted by Michael Wonder on 13 Apr 2021
Four medicines accepted for use by NHS Scotland
13 April 2021 - The Scottish Medicines Consortium has approved NHS funding for four new medicines, including treatments for multiple myeloma and severe migraine in its April 2020 decisions.
Firstly, Sanofi's Sarclisa (isatuximab) has been accepted by the SMC for the treatment of relapsed or refractory multiple myeloma, in combination with two other medicines - pomalidomide and dexamethasone.
